delirium
TRANSCRIPT
![Page 1: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/1.jpg)
Moderator : Dr. M. Amir
Usmani
DELIRIUM
Presented by : Dr. Karrar
Husain
![Page 2: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/2.jpg)
INTRODUCTION
HISTORY
![Page 3: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/3.jpg)
INTRODUCTION
Delirium is an acute transient disturbance in consciousnessthat is characterized by a change in cognition manifestprimarily by an impairment of attention.
The patient's inability to focus, sustain, or shift attention canresult in the impairment of other neurobehavioral tasks (e.g.,memory).
Language and visual spatial skills also can be affected.
Lipowski Z: Delirium: Acute confusional states. New York, Oxford University Press,
1990
Lipowski Z: Delirium (Acute confusional states). JAMA 258:1789, 1987
![Page 4: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/4.jpg)
Changes in cognition seen in delirium are not explained by anunderlying dementia.
These changes fluctuate considerably during a 24-hour periodand tend to be more pronounced at night.
![Page 5: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/5.jpg)
Intensive care unit psychosis
Acute confusional state
Acute brain failure
Encephalitis
Encephalopathy
Toxic metabolic state
Central nervous system toxicity
Cinchonism
Paraneoplastic limbic encephalitis
Sundowning
Cerebral insufficiency
Organic brain syndrome
CTP 9th ed
![Page 6: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/6.jpg)
HISTORY
Hippocrates - 5th century BC- a clinical entity, poor prognosticsign.
Celsus, 1st century - first to use the term delirium anddistinguished it from hysteria, depression, and mania.
The term delirium originates from latin word delirio –to becrazy.
CTP 9th ed
![Page 7: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/7.jpg)
2nd century AD, Galen differentiated between primary andsecondary types of delirium.
19th century emphasis was placed on disturbed consciousnessas the hallmark of delirium.
George angel and romano – 19th century, demonstrated thatdelirium is due to reduction in metabolic activity
The first modern standardized criteria for the diagnosis -DSM,3rd edition (DSM-III) published in 1980.
Levkoff S, Marcantonio E: Delirium: A major diagnostic and therapeutic challenge for
clinicians caring for the elderly. Comp Ther 20:550, 1994
Lipowski Z: Delirium: Acute confusional states. New York, Oxford University Press,
1990
![Page 8: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/8.jpg)
Substantial alterations of the diagnostic criteria for deliriumwere made in the 1987 revision of the manual, DSM-IIIR.
The 1994 revision, DSM-IV, divides the criteria for diagnosingdelirium into five separate categories
DSM 5……
![Page 9: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/9.jpg)
EPIDEMIOLOGY
ETIOLOGY
NEUROPATHOLOGY
![Page 10: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/10.jpg)
EPIDEMIOLOGY
There have been relatively few studies of the incidence andprevalence of delirium.
Little is known about the epidemiology of delirium incommunity or other non patient, non-institutionalizedpopulations.
![Page 11: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/11.jpg)
CTP 9th ed
![Page 12: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/12.jpg)
Among the elderly :
10-15% have delirium on admission
10-40% develop delirium during the course of their hospital
(Bucht et al, 1999; Fann, 2000).
![Page 13: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/13.jpg)
Prevalence of delirium in different populations
General population: 0.4%
General population (>55 yrs): 1.1%
General hospital admissions: 9-30%
Elderly general hospital admissions: 5-55%
Elderly accident and emergency attenders: 16%
(Meagher, 2001)
![Page 14: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/14.jpg)
AIDS: 17-40%
Cancer patients (terminal stages): 25-40%
Postoperative patients: 5-75%
ICU patients: 12-50%
Nursing home residents : 60%
(Meagher, 2001)
![Page 15: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/15.jpg)
In patients undergoing mechanical ventilation prevalence ashigh as 80% (Riker et al, 2009)
13–28% patients with ischemic stroke, subarachnoidhemorrhage or intracerebral hemorrhage have delirium.
(Caeiro et al, 2004, McManus et al, 2009; Sheng et al, 2006)
In critically ill patients on mechanical ventilation it isassociated with increased short term and 6-month mortality,increased mechanical ventilation days, longer ICU stay, andhospital stay. (Ely et al, 2004, Lat et al, 2009,Shehabi et al,2010)
![Page 16: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/16.jpg)
Delirium is common in patients referred to consultation-liaison psychiatry services.
10% of consultation-liaison referrals have delirium andaround 10% of delirious general hospital patients receive apsychiatric consultation
(Sirois, 1988; Francis et al, 1990).
![Page 17: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/17.jpg)
SIGNIFICANCE
Increased healthcare cost –
• longer hospitalizations,
• increased requirements for nursing care and supervision,
• increased incidence of nursing home placement afterdischarge.
Higher rate of mortality than do nondelirious patients withthe same underlying medical condition.
![Page 18: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/18.jpg)
Delirious patients pose a potential medico legal risk –
1. informed consent;
2. risk to escape;
3. aggressive behavior;
4. risk for falls or self-injury.
They are poorly cooperative with necessary procedures andtherapy, and thus further complicating their underlyingmedical condition.
![Page 19: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/19.jpg)
RISK FACTORS
Risk for delirium could be conceptualized into twocategories :
1. Pre-disposing
2. Precipitating factors
Managing predisposing factors for delirium becomes essentialin decreasing future episodes of delirium and the morbidityand mortality associated with it.
![Page 20: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/20.jpg)
CTP 9th ed
PRE-DISPOSING
![Page 21: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/21.jpg)
CTP 9th ed
PRE-DISPOSING
![Page 22: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/22.jpg)
CTP 9th ed
PRECIPITATING FACTORS
![Page 23: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/23.jpg)
CTP 9th ed
PRECIPITATING FACTORS
![Page 24: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/24.jpg)
CTP 9th ed
PRECIPITATING FACTORS
![Page 25: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/25.jpg)
Practically any physiologic derangement can cause delirium ina susceptible individual.
As currently conceptualized, delirium is a thresholdphenomena, where systemic and cerebral insults arecumulative.
![Page 26: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/26.jpg)
In a prospective study of delirium in elderly patients, Francisand colleagues identified five leading causes of delirium.
1. Fluid/electrolyte disturbance
2. Infection
3. Medication toxicity
4. Metabolic derangement
5. Sensory and environmental disturbance
![Page 27: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/27.jpg)
Protective factors
Good premorbid functioning before delirium.
Early recognition have a significant impact on improvingpatient outcome and reduce the cost of caring for deliriouspatients
![Page 28: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/28.jpg)
NEUROPATHOPHYSIOLOGY
Anatomical areas
Prefrontal cortex,
Right cerebral hemisphere (esp. parietal), and
Sub cortical nuclei (esp. right sided thalamus & caudate).
(Trzepacz, 1994)
![Page 29: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/29.jpg)
NEUROTRANSMISSION
Cholinergic,
Dopaminergic,
Serotonergic And GABA-ergic Systems With NA,
Glutaminergic,
Opiatergic And Histaminergic Systems.
![Page 30: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/30.jpg)
ACETYLCHOLINE - decreased
• Anti cholinergic medications
• B1 deficiency
• Hypoxia Ach.
• Hypoglycemia
Experimental delirium
![Page 31: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/31.jpg)
DA:
Increased Dopamine activity
Administration of anti DA-ergic drugs treat delirium
Delirium from intoxication with DA ergic drug (L-dopa,dopamine, bupropion).
Opiates, common cause of delirium, increase activity of DAand glutamate, whereas they that of Ach.
Hypoxia, DA and Ach
![Page 32: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/32.jpg)
GABA
Delirium in conditions that either (e.g. hepaticencephalopathy) or (e.g. hypnosedative withdrawal).
5HT
Postulated as either or in different types of delirium: hepatic encephalopathy and serotonin syndrome
Decreased in post cardiotomy patients with delirium andwithdrawal from serotonergic drugs .
(Vander Mast, 1994).
![Page 33: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/33.jpg)
Histamine
Antihistamines (H1 antagonists) are associated with deliriumesp. in the elderly. They also increase catechols and serotoninas possible mechanisms for delirium. (Tejera, 1994)
H2 blockers – associated with delirium, mechanism isuncertain, probably anticholinergic action. (Jones, 1986)
![Page 34: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/34.jpg)
Glutamate
Glutamate excitatory neurotoxicity via NMDA receptor apoptosis and neuronal death associated with alcoholintoxication and withdrawal, delirium.
NMDA antagonists, such as phencyclidine (PCP) andketamine, are also associated with delirium
![Page 35: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/35.jpg)
Cytokines
Delirium from inflammatory or infectious causes.
(Manos, 1995; Ovsiew, 1995).
Therapeutic administration of some cytokines, such asinterferons and interleukins has been reported to causedelirium, perhaps related to d b-b-b permeability.
Cytokines may influence activity of neurotransmittersystems, such as catecholamines, GABA and acetylcholine
(Rothwell, 1995)
![Page 36: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/36.jpg)
Oxidative Metabolism
Disturbance in brain oxygen supply versus demand has been one of the theories proposed for delirium.
Impaired oxidative metabolism appears to be a predisposing factor for later development of delirium.
![Page 37: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/37.jpg)
DIAGNOSIS AND CF
DIFFERENTIAL
DIAGNOSIS
COURSE
![Page 38: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/38.jpg)
CLASSIFICATION
Delirium is classified in DSM 5 in chapter of neurocognitivedisorders, which consist of delirium, major NCD, mild NCDand their etiological subtypes.
In ICD 10- F00-F09 Organic, including symptomatic, mentaldisorders.. F05
F10-F19 Mental and behavioural disorders due topsychoactive substance use with individual substance.
DSM 5
ICD-10
![Page 39: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/39.jpg)
DSM 5
Diagnostic Criteria
A. A disturbance in attention (i.e., reduced ability to direct,focus, sustain, and shift attention) and awareness (reducedorientation to the environment).
B. The disturbance develops over a short period of time (usuallyhours to a few days), represents a change from baselineattention and awareness, and tends to fluctuate in severityduring the course of a day.
C. An additional disturbance in cognition (e.g., memory deficit,disorientation, language, visuospatial ability, or perception).
![Page 40: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/40.jpg)
D. The disturbances in Criteria A and C are not better explainedby another preexisting, established, or evolvingneurocognitive disorder and do not occur in the context of aseverely reduced level of arousal, such as coma.
E. There is evidence from the history, physical examination, orlaboratory findings that the disturbance is a directphysiological consequence of another medical condition,substance intoxication or withdrawal (i.e., due to a drug ofabuse or to a medication), or exposure to a toxin, or is due tomultiple etiologies.
![Page 41: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/41.jpg)
Specify whether
(1) substance intoxication delirium
(2) substance withdrawal delirium
(3) medication induced delirium
(4) delirium due to another medical condition
(5) delirium due to multiple etiologies
![Page 42: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/42.jpg)
Specify if
1. Acute – lasting a few hours or day
2. Persistent- lasting weeks or months
Specify if
1. Hyperactive
2. Hypoactive
3. Mixed level of activity
![Page 43: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/43.jpg)
Associated feature supporting diagnosis :
• Disturbance in sleep wake cycle
• Emotional disturbance like anxiety, fear, depression,euphoria, anger, irritability and apathy. There may be rapidand unpredictable shift from one state to another.
OTHERS - Other specified delirium, Unspecified delirium
![Page 44: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/44.jpg)
ICD-10
F05 Delirium, not induced by alcohol and other psychoactivesubstances
• F05.0 Delirium, not superimposed on dementia, so described
• F05.1 Delirium, superimposed on dementia
• F05.8 Other delirium
• F05.9 Delirium, unspecified
![Page 45: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/45.jpg)
FO5 DELIRIUM, NOT INDUCED BY ALCOHOL AND OTHERPSYCHOACTIVE SUBSTANCES
A. Clouding of consciousness, i.e. reduced clarity of awareness ofthe environment, with reduced ability to focus, sustain, orshift attention.
B. Disturbance of cognition, manifest by both:
1. impairment of immediate recall and recent memory, withrelatively intact remote memory;
2. disorientation in time, place or person.
![Page 46: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/46.jpg)
C. At least one of the following psychomotor disturbances:
1. rapid, unpredictable shifts from hypo-activity to hyper-activity;
2. increased reaction time;
3. increased or decreased flow of speech;
4. enhanced startle reaction.
![Page 47: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/47.jpg)
D. Disturbance of sleep or the sleep-wake cycle, manifest by atleast one of the following:
1. insomnia, which in severe cases may involve total sleep loss,with or without daytime drowsiness, or reversal of thesleep-wake cycle;
2. nocturnal worsening of symptoms;
3. disturbing dreams and nightmares which may continue ashallucinations or illusions after awakening.
![Page 48: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/48.jpg)
E. Rapid onset and fluctuations of the symptoms over the courseof the day.
F. Objective evidence from history, physical and neurologicalexamination or laboratory tests of an underlying cerebral orsystemic disease (other than psychoactive substance-related)that can be presumed to be responsible for the clinicalmanifestations in A-D.
![Page 49: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/49.jpg)
Recognizing warning Signs of Delirium
Acute change in mental status
Presence of medical illness
Visual hallucinations
Fluctuating levels of consciousness
Acute onset of psychiatric symptoms without prior history of psychiatric illness
![Page 50: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/50.jpg)
Acute onset of new or different psychiatric symptoms withhistory of prior psychiatric illness
Patient described as “confused” or “disoriented”
Diffuse slow waves or epileptiform discharges onelectroencephalogram.
![Page 51: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/51.jpg)
SCALES
Confusion Assessment Method (CAM) and CAM-ICU forcritically ill patients
Severity of delirium –
1. Delirium Rating Scale (DRS),
2. Memorial Delirium Assessment Scale (MDAS)
![Page 52: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/52.jpg)
DIFFERENTIAL DIAGNOSIS
Depression
Dementia
Schizophrenia
Adjustment disorders,
Anxiety disorders,
Agitated depression
Mania
CTP 9th ed
![Page 53: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/53.jpg)
![Page 54: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/54.jpg)
COURSE AND PROGNOSIS
By the third hospital day, approximately one-half the patientswho are diagnosed with delirium have been diagnosed.
Symptoms of delirium usually last 3 to 5 days, but there isslow resolution of symptoms contributing to persistentsymptoms of delirium at 6 to 8 weeks for severely ill patients.
Symptom resolution is frequently incomplete by hospitaldischarge, with as many as 15 percent of patients remainingsymptomatic of delirium at 6 months.
CTP 9th ed
![Page 55: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/55.jpg)
In general, studies suggest that the increased mortality riskassociated with delirium was maintained at 12, 24, and 36months with a risk ratio of at least 2 at all time points.
Additionally, at 24 months, the increased risk of cognitive andfunctional impairment remained.
![Page 56: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/56.jpg)
PREVENTION
MANAGEMENT
![Page 57: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/57.jpg)
PREVENTION
Primary prevention
Minimization of polypharmacy.
Anti cholinergic, hypnosedative and opioid medicationsshould be used sparingly in the elderly.
Maintain hydration and nourishment and ensure sufficientsleep.
Caregivers and nursing staff must be trained to recognizedelirium.
![Page 58: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/58.jpg)
Secondary prevention
Early diagnosis and treatment
Improved recognition of the condition.
It is recommended that all acutely ill elderly patients shouldhave a brief mental test on admission to increase the rate ofdetection of delirium.
Environment modifications, close monitoring to preventfurther morbidity and mortality.
(Jitapunkul et al,
1992).
![Page 59: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/59.jpg)
MANAGEMENT
Basic algorithm for initial delirium management
1. Taper or discontinue non-essential medications.
2. Close observation.
3. Monitor vital signs and fluid intake and outputs.
4. Complete history and perform initial laboratory studies.
![Page 60: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/60.jpg)
5. Implement environment and psychosocial interventions.
6. Pharmacological treatment as indicated.
7. Physical restraints are used only as a last resort.
![Page 61: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/61.jpg)
Setting
Considering the morbidity and mortality rates associated withdelirium and the need for its timely, definitive treatment,inpatient care is almost always required.
Definitive treatment is directed towards the condition(s)causing the syndrome, whereas palliative treatment isdirected toward control of symptoms such as agitation.
![Page 62: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/62.jpg)
LABORATORY EVALUATION
Basic Laboratory Examination:
1. Complete blood count with differential,
2. Serum chemistries,
3. Urine analysis,
4. EKG,
5. Chest radiograph,
6. Pulse oxymetry-arterial blood gas.
![Page 63: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/63.jpg)
Additional Laboratories Based on History, Examination,Laboratories:
• Serum-urine drug screens;
• Drug levels;
• Vitamin B12 ; folate;
• Thyroid tests;
• Ammonia levels;
• Blood-urine cultures;
![Page 64: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/64.jpg)
• EEG (seizure disorder);
• CT or MR imaging (focal neurologic deficits or suspectedtrauma);
• Cerebrospinal fluid examination.
![Page 65: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/65.jpg)
In the future, a measure of total serum anticholinergicactivity may prove helpful in deciding whether to discontinuesome or all medications.
This is a radioreceptor assay that has been validated atseveral centers; however, it is not yet available commercially.
![Page 66: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/66.jpg)
EEG
• Slowing of the posterior dominant rhythm and increasedgeneralized slow-wave activity.
• As delirium worsens and as the EEG background rhythmreaches 5 to 6 Hz or less, reactivity is lost.
• The magnitude of change in frequency of the posteriordominant rhythm is more important than the absolutefrequency.
![Page 67: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/67.jpg)
NEUROIMAGING : Structural brain imaging may detect acuteor subacute conditions, such as
• Subarachnoid hemorrhage,
• Subdural hematomas,
• Intracranial tumors, and
• Vascular changes, including stroke,
may cause or contribute to a delirium.
![Page 68: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/68.jpg)
NON PHARMACOLOGICAL INTERVENTION
Ensure effective communication & reorientation (e.g.explaining where the person is, who they are, and what yourrole is)
Promoting day activity
Maintaining quite, well-lit environment
Staff continuity
Avoiding room and bed changes
Providing hearing and visual aids
![Page 69: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/69.jpg)
Encouraging personal items
Limiting visits especially for hyperactive delirium patients,
Remove noxious stimuli (e.g., catheters, pumps, etc.)
Normal sleep–wake cycles can be promoted by the use of daytime activity and environmental cues (such as windows andclocks).
Interruptions of sleep should be minimized when possible.
Adequate nutrition.
![Page 70: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/70.jpg)
PHARMACOLOGICAL INTERVENTION
General principles
• Keep the use of sedatives and antipsychotics to a minimum.
• Use one drug at a time.
• Titrate doses to effect.
• Review at least every 24 hours. Once an effective has beenestablished, a regular dose should be prescribed.
• Maintain at an effective dose and discontinue 7–10 days aftersymptoms resolve.
Maudsley prescribing
guidelines
![Page 71: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/71.jpg)
Psychoactive medications are indicated for deliriumassociated with drug withdrawal or for behaviors that pose asafety risk for the patient and others.
Two general classes of agents—
• Antipsychotics and
• Benzodiazepines
![Page 72: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/72.jpg)
Antipsychotics are effective in alleviating a range of deliriumsymptoms in patients with either hypoactive or hyperactiveclinical profiles.
The therapeutic impact is due to their sedative effects and byeffects on the dopamine-acetylcholine balance.
(Platt et al, 1994).
![Page 73: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/73.jpg)
Haloperidol is the preferred drug because it is potent and hasfewer anti cholinergic and hypotensive side effects.
Therapy should be monitored closely for side effects.
Haloperidol can be administered through oral, intravascular,intravenous routes though intravenous route is not approvedby US FDA.
(Adams 1984, 1988),
![Page 74: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/74.jpg)
Intravenous route
• Potency is twice that of oral dose.
• Fast onset of action (3-19 minutes)
• Elimination T ½ is 10-19 hours.
(Friedman, 1995).
(Gelfand, 1992)
![Page 75: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/75.jpg)
Advantages
Relatively safe side-effect profile.
Haloperidol has surprisingly infrequent extrapyramidal sideeffects when used intravenous.
IV haloperidol does not interfere with dopamine-inducedincreases in renal blood flow
(Gelfand, 1985; Moulaert, 1989; Tesar, 1986); Armstrong, 1986; Fernandez, 1988
![Page 76: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/76.jpg)
Dosing
Oral 0.5–1 mg bd with additional doses every 4 hours asneeded
IM 0.5–1 mg, observe for 30–60 minutes and repeat ifnecessary (peak effect: 20–40 minutes)
CTP 9th ed
![Page 77: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/77.jpg)
Second-generation antipsychotics, such as risperidone,clozapine, olanzapine, quetiapine, ziprasidone, andaripiprazole, may be considered.
But these agents are associated with increased mortality inpatient of dementia.
For patients with Parkinson's disease and delirium whorequire antipsychotic medications, clozapine or quetiapinehave some support in the literature.
CTP 9th ed
![Page 78: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/78.jpg)
Advances in Psychiatric Treatment (2008), vol. 14, 292–301, BJPsych advances
![Page 79: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/79.jpg)
Benzodiazepines are also used in the management ofdelirium to sedate the agitated patient.
When the agitation is associated with sedative-hypnotic andalcohol withdrawal, benzodiazepines are the treatment ofchoice.
Dosing : Lorazepam –0.5–3 mg a day and as needed every4hr.
BZD may worsen delirium and may cause respiratorydepression.
![Page 80: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/80.jpg)
Cholinestrase inhibitors
Donezepil 5mg OD, very little evidence
Rivastigmine 3-9 mg OD, very little experience, usually usedin chronic delirium as an adjunct to antipsychotics.
Others
Melatonin 2mg OD, used to correct sleep wake cycle
Sodium valproate, some case reports of its use whenantipsychotics and benzodiazepenes are not effective.
Maudsley prescribing
guidelines
![Page 81: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/81.jpg)
Electroconvulsive Therapy
It has been used as a last resort for delirious patients withsevere agitation who are not responsive to pharmacotherapy.
The ECT is usually given en bloc or daily for several days,sometimes with multiple treatments per day.
![Page 82: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/82.jpg)
![Page 83: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/83.jpg)
Advances in Psychiatric Treatment (2008), vol. 14, 292–301, BJPsych advances
![Page 84: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/84.jpg)
Advances in Psychiatric Treatment (2008), vol. 14, 292–301, BJPsych advances
![Page 85: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/85.jpg)
Advances in Psychiatric Treatment (2008), vol. 14, 292–301, BJPsych advances
![Page 86: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/86.jpg)
Advances in Psychiatric Treatment (2008), vol. 14, 292–301, BJPsych advances
![Page 87: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/87.jpg)
Sleep–Wake Cycle
• Delirium is frequently complicated by changes in the sleep–wake cycle.
• Sedating medicines – bedtime
• Stimulating medicines or caffeine in morning
• Brief, judicious use of sedating agents, such as zolpidem ortrazodone, to reset the sleep–wake cycle may be appropriate.
![Page 88: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/88.jpg)
AFTER CARE:
Many patients are discharged before their symptoms are fullyresolved.
Problems with attention and orientation are especiallypersistent (Levkoff et al, 1994).
Depression, post traumatic stress disorder (PTSD) arerecognized as psychological sequelae.
![Page 89: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/89.jpg)
CONCLUSION
• Delirium is complex neuropsychiatric syndrome that iscommon in all health care settings.
• The field is hampered by poor detection.
• Psychiatrists can play a pivotal role in the diagnosis andtreatment of delirious patients.
• Typical neuroleptic drugs remain the cornerstone oftreatment.
![Page 90: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/90.jpg)
• Cognitive impairment of delirium is not entirely reversible inall patients.
• During delirium there is significant risk for progression ofunderlying dementia.
• Symptoms of delirium frequently persists beyond the acutephase of treatment, therefore post-discharge treatment plansmust focus on reducing ongoing risk factors and managingresidual functional impairment.
![Page 91: Delirium](https://reader030.vdocuments.us/reader030/viewer/2022032616/55a677731a28abc2758b4693/html5/thumbnails/91.jpg)
Thank
you